484 Results (Page 19 of 20)
UAE Markets Research Reports
UAE Dental Implant Market Analysis
UAE Dental Implant Market was valued at $24.90 Mn in 2023 and is predicted to grow at a CAGR of 10.8% from 2023 to 2030, to $51.10 Mn by 2030. The key drivers of this industry include rising demand for aesthetics, a growing aging population, growing awareness of benefits, and improved dental technology. The industry is primarily dominated by Straumann Group, Dentsply Sirona, Zimmer Biomet Ltd, and Henry Schein Holdings Ltd among others.
UAE PET Scan Market Analysis
The UAE PET Scan Market was valued at $9.7 Mn in 2023 and is predicted to grow at a CAGR of 6.4% from 2023 to 2030, to $15 Mn by 2030. The key drivers of the market include the rise in elderly population, increasing prevalence of chronic diseases, and increasing healthcare expenditure. The prominent players of the UAE PET Scan Market are Philips Healthcare, Toshiba Medical Systems, Hitachi Medical Systems, Shimadzu, and Mediso Medical Imaging Systems, among others.
UAE Conjunctivitis Therapeutics Market Analysis
The UAE Conjunctivitis Therapeutics Market was valued at $21 Mn in 2022 and is predicted to grow at a CAGR of 6.4% from 2023 to 2030, to $34 Mn by 2030. The key drivers of this industry include a surge in the prevalence of conjunctivitis, increasing government investments, and technological advancements in the therapeutics industry. The industry is primarily dominated by players such as Novartis, Pfizer, Bausch & Lomb, Julphar, Santen, and Neopharma among others.
UAE Genomic Diagnostics Market Analysis
UAE Genomic Diagnostics Market was valued at $163.25 Mn in 2023 and is predicted to grow at a CAGR of 17.5% from 2023 to 2030, to $504.80 Mn by 2030. The key drivers of this industry include rising prevalence of genetic conditions, growing awareness, and technological advancements. The industry is primarily dominated by Illumina, 23andMe, Myriad Genetics, and Amgen among others.
UAE Ear Infection Therapeutics Market Analysis
UAE Ear Infection Therapeutics Market valued at $59 Mn in 2022, is projected to reach $95 Mn by 2030 with a 6.2% CAGR. The rising incidence of ear infections, particularly among children, significantly drives the growth of the ear infection therapeutics market, acting as a catalyst for extensive research, development, and the availability of treatments to address this widespread medical condition. Notable companies in this sector encompass Pfizer, GlaxoSmithKline, Johnson & Johnson, Merck & Co., Eli Lilly, Novartis, Teva Pharmaceutical, Mylan, Hikma Pharmaceuticals, and Sun Pharmaceutical.
UAE Mouth Ulcer Therapeutics Market Analysis
The UAE Mouth Ulcer Therapeutics Market was valued at $7.6 Mn in 2023 and is projected to grow at a CAGR of 4.9% from 2023 to 2023, to $10.6 Mn by 2030. The key drivers of this industry are rising awareness about oral hygiene, increasing demand for rapid healing products, growing geriatric population, rise in tobacco consumption, increasing incidence of oral diseases, chemical-based toothpaste and unhealthy lifestyles etc. The industry is primarily dominated by players such as Blistex Inc, Bristol-Myers Squibb Company, Church & Dwight Co, Inc, Colgate-Palmolive Company, GlaxoSmithKline PLC, Pfizer, Inc. among others.
UAE Compression Therapy Market Analysis
UAE Compression Therapy Market was valued at $19 Mn in 2022 and is estimated to reach $32 Mn in 2030, exhibiting a CAGR of 6.6% during the forecast period. The increasing occurrence of venous conditions such as leg ulcers, deep vein thrombosis, lymphedema, varicose veins, and blood clots is a major factor contributing to the expansion of the compression therapy market. Leading companies in this sector include Medi France, Sigvaris, Juzo, Bauerfeind, Jobst, Lympha Press, FLA Orthopedics, Al-Johaifa Medical, Nahdi Pharmacy, and AstraZeneca.
UAE CT Scan Market Analysis
UAE CT Scan Market was valued at $23.05 Mn in 2023 and is predicted to grow at a CAGR of 8.87% from 2023 to 2030, to $41.79 Mn by 2030. The key drivers of this industry include the rising prevalence of chronic diseases, the growing population, and government investments in healthcare. The industry is primarily dominated by GE HealthCare, Siemens Healthineers, Canon Medical Systems, and NeuroLogica Corp. among others.
UAE Cough Hypersensitivity Syndrome Therapeutics Market Analysis
The UAE Cough Hypersensitivity Syndrome Therapeutics Market was valued at $41 Mn in 2022 and is predicted to grow at a CAGR of 6.9% from 2023 to 2030, to $69 Mn by 2030. The key drivers of this industry include the rising prevalence of Cough Hypersensitivity Syndrome, supportive government initiatives, and the development of novel therapeutics. The industry is primarily dominated by players such as Sanofi, Pfizer, Akorn, Novartis, Johnson & Johnson, and GSK among others.
UAE Bio-Implant Market Analysis
The UAE Bio-implant Market was valued at $325 Mn in 2023 and is predicted to grow at a CAGR of 6.9% from 2023 to 2030, to $518.5 Mn by 2030. The UAE Bio-implant Market is growing due to the Growing Aging Population, Government Initiatives and Healthcare Infrastructure Development, and Rising Chronic Disease Prevalence. The market is primarily dominated by players such as ProvenMed, Global Med Hub FZ LLC, Sinterex, ThermoMind, Zimmer Biomet, Boston Scientific Corporation, Otto Bock Holding GmbH & Co. KG, and Medtronic plc.
UAE Herbal Supplements Market Report
The UAE Herbal Supplements Market was valued at $26.30 Mn in 2023 and is predicted to grow at a CAGR of 7.2% from 2023 to 2030, to $42.79 Mn by 2030. The key drivers of this industry include health and wellness trends, cultural influence, and government initiatives. The industry is primarily dominated by players such as Himalaya Wellness, Dabur, Herbalife Nutrition, and Healwell Pharma among others.
UAE Brugada Syndrome Market Analysis
The UAE Brugada Syndrome Market was valued at $6 Mn in 2023 and is predicted to grow at a CAGR of 8.8% from 2023 to 2030, to $10.8 Mn by 2030. The key drivers of the market include growing prevalence of cardiovascular diseases, aging population, and advancements in genetic testing. The prominent players of the UAE Brugada Syndrome Market are Julphar, Neopharma, Novartis, Boehringer Ingelheim, and Gulf Scientific Corporation, among others.
UAE Clinical Nutrition for Chronic Kidney Diseases Market Analysis
UAE Clinical Nutrition for Chronic Kidney Diseases Market was valued at $7.80 Mn in 2023 and is predicted to grow at a CAGR of 7.03% from 2023 to 2030, to $12.60 Mn by 2030. The key drivers of this industry include the rising prevalence of CKD, growing awareness and diagnosis, advancements in medical research, and the aging population. The industry is primarily dominated by Abbott Nutrition, Pfizer Inc., Bayer AG, and Nestlé Health Science among others.
UAE Brain Cancer Therapeutics Market
UAE Brain Cancer Therapeutics Market valued at $12 Mn in 2022, projected to reach $28 Mn by 2030 with a 11.6% CAGR. The market for brain cancer therapeutics is expected to be driven by the anticipated rise in the incidence of brain cancer, especially glioblastoma multiforme, which would raise the demand for therapeutics. Among the prominent players in the pharmaceutical sector are Roche, Merck, Novartis, Bristol Myers Squibb, Eli Lilly, Pfizer, AstraZeneca, Teva Pharmaceutical Industries, Sanofi, and Ipsen.
UAE Dental Endodontics Market Analysis
UAE Dental Endodontics Market was valued at $8.80 Mn in 2023 and is predicted to grow at a CAGR of 5.3% from 2023 to 2030, to $12.60 Mn by 2030. The key drivers of this industry include growing demand, rising prevalence of dental problems, and technological advancements. The industry is primarily dominated by Coltene, Dentsply Sirona, FKG Dentaire, and Ultradent Products among others.
UAE Clinical Nutrition Market Analysis
The UAE Clinical Nutrition Market was valued at $153.3 Mn in 2023 and is projected to grow at a CAGR of 6.34% from 2023 to 2023, to $235.8 Mn by 2030. The key drivers of this industry are increasing prevalence of chronic diseases and metabolic disorders, aging population, increasing awareness of the importance of nutrition for health, product innovations and technological advancements, government initiatives and rising healthcare expenditure, rising incidence of malnutrition especially in paediatric patients which has contributed to market growth. The industry is primarily dominated by players such as BASF, B Braun, Abbott Nutrition, Pfizer Inc, Bayer AG, Nestle, Baxter International Inc., Otsuka Holdings Co., Ltd among others.
UAE Breast Pump Market Report
The UAE Breast Pump Market was valued at $14.7 Mn in 2023 and is predicted to grow at a CAGR of 9.6% from 2023 to 2030, to $27.9 Mn by 2030. The key drivers of the market include the rising female workforce, technological advancements, and consumer awareness. The prominent players of the UAE Breast Pump Market are Ardo, Nubeca, Playtex, Ameda, Avent, and Evenflo, among others.
UAE Blood Disorder Therapeutics Market
UAE Blood Disorder Therapeutics Market valued at $67 Mn in 2022, projected to reach $129 Mn by 2030 with a 8.5% CAGR. The UAE's political and economic stability, regional healthcare initiatives, aging populations, rising lifestyle trends that are contributing to an increase in chronic diseases, and improvements in diagnostic technologies that are providing more targeted and effective treatments are the main factors driving the market's growth. The UAE Blood Disorder Therapeutics Market encompasses various players across different segments, including Pfizer, Novartis, Roche, Bayer, Takeda Pharmaceuticals, Gilead, Sanofi, Neopharma, Julphar, Sun Pharma etc, among various others.
UAE Digital Biomarkers Market Analysis
UAE Digital Biomarkers Market was valued at $14.50 Mn in 2023 and is predicted to grow at a CAGR of 23.3% from 2023 to 2030, to $62.82 Mn by 2030. The key drivers of this industry include the rising prevalence of chronic diseases, government initiatives, increased tech adoption, and focus on preventative care. The industry is primarily dominated by ActiGraph LLC, AliveCor Inc., Koneksa, and Altoida Inc. among others.
UAE Medication Access Programs Market Analysis
The UAE Medication Access Programs Market was valued at $27.4 Mn in 2023 and is predicted to grow at a CAGR of 15.6% from 2023 to 2030, to $75.7 Mn by 2030. The key drivers of this industry include increasing healthcare expenditure, government initiatives, and the rising prevalence of chronic disease. The industry is primarily dominated by players such as Gilead Sciences, Takeda Pharmaceuticals, Pfizer, and Novartis among others.
UAE Congestive Heart Failure Therapeutics Market Analysis
The UAE Congestive Heart Failure Therapeutics Market is anticipated to experience a growth from $52 Mn in 2022 to $87 Mn by 2030, with a CAGR of 6.8% during the forecast period of 2022-2030. The market is growing due to the presence of increasing government initiatives that actively encourage research and collaboration, the rising prevalence of cardiovascular disease, and a favorable environment conducive to advancements in therapeutics. The UAE Congestive Heart Failure Therapeutics Market encompasses various key players across different therapeutic segments, including Johnson & Johnson, Merck, Novartis, Pfizer, Sanofi, AstraZeneca, Julphar, RAK Pharma, Pharmed, Cipla, etc, among various others.
UAE Cardiac Resynchronization Therapy Market
UAE Cardiac Resynchronization Therapy Market valued at $24 Mn in 2022, projected to reach $38 Mn by 2030 with a 6% CAGR. The increasing worldwide incidence of heart failure, propelled by aging demographics and cardiovascular diseases linked to lifestyle, emerges as a significant factor fuelling the growth of the Cardiac Resynchronization Therapy (CRT) market. Presently, prominent players in this market encompass Abbott, Boston Scientific, Medtronic, Siemens Healthineers, Johnson & Johnson, Biotronik, LivaNova, MicroPort, Sorin Group, and St. Jude Medical.
UAE Physiotherapy Equipment Market Analysis
The UAE Physiotherapy Equipment Market was valued at $104.50 Mn in 2023 and is predicted to grow at a CAGR of 8.2% from 2023 to 2030, to $181.43 Mn by 2030. The key drivers of this industry include the rising prevalence of chronic diseases, expanding geriatric population, and advancements in technology. The key players in the industry are HMS Medical Systems, Medicaregt, EMS Physio Ltd., and Bionex Medical Equipment among others.
UAE Patient Adherence Programs Market Analysis
The UAE Patient Adherence Programs Market was valued at $64.8 Mn in 2023 and is predicted to grow at a CAGR of 19% from 2023 to 2030, to $218.9 Mn by 2030. The key drivers of the market include increasing non-adherence, rising chronic conditions, and an aging population. The prominent players in the UAE Patient Adherence Programs Market are Medspero Pharma, Julphar Gulf Pharmaceuticals, Neopharma, Globalpharma, Medpharma, Avernus Pharma, and Lavasta Pharma, among others.
UAE Dental Consumables Market Analysis
The UAE Dental Consumables Market was valued at $169 Mn in 2023 and is projected to grow at a CAGR of 9.0% from 2023 to 2023, to $308.9 Mn by 2030. The key drivers of this industry growing dental care needs, technological advancements, expanding dental infrastructure, increasing disposable incomes, public health initiatives, dental tourism, rising consumption of sugary and starchy foods, rise in unhealthy eating habits due to rising urbanization, changing living standards. The industry is primarily dominated by players such as Dubai Medical Equipment LLC, Advanced Healthcare Medical Equipment LLC, Dentsply Sirona, Danaher, Align Technology, 3M, among others.